OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
To boost compostable packaging, resin innovation, and supply chain speed
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Paves the way for next-gen ultra-precise gas sensing
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
Subscribe To Our Newsletter & Stay Updated